These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25867243)

  • 1. Contrast imaging in mouse embryos using high-frequency ultrasound.
    Denbeigh JM; Nixon BA; Puri MC; Foster FS
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos.
    Denbeigh JM; Nixon BA; Lee JJ; Jerkic M; Marsden PA; Letarte M; Puri MC; Foster FS
    Angiogenesis; 2015 Jan; 18(1):69-81. PubMed ID: 25298070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
    Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
    Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
    Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
    Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
    Deshpande N; Ren Y; Foygel K; Rosenberg J; Willmann JK
    Radiology; 2011 Mar; 258(3):804-11. PubMed ID: 21339349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
    Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
    Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of microbubble size on fundamental mode high frequency ultrasound imaging in mice.
    Sirsi S; Feshitan J; Kwan J; Homma S; Borden M
    Ultrasound Med Biol; 2010 Jun; 36(6):935-48. PubMed ID: 20447755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
    Wang S; Herbst EB; Mauldin FW; Diakova GB; Klibanov AL; Hossack JA
    Invest Radiol; 2016 Dec; 51(12):758-766. PubMed ID: 27654582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
    Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
    Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.
    Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ
    Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Endothelial αvβ3 Expression with High-Frequency Ultrasound and Targeted Microbubbles: In Vitro and In Vivo Studies.
    Daeichin V; Kooiman K; Skachkov I; Bosch JG; Theelen TL; Steiger K; Needles A; Janssen BJ; Daemen MJ; van der Steen AF; de Jong N; Sluimer JC
    Ultrasound Med Biol; 2016 Sep; 42(9):2283-93. PubMed ID: 27302657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
    Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
    J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tissue perfusion by contrast-enhanced ultrasound.
    Quaia E
    Eur Radiol; 2011 Mar; 21(3):604-15. PubMed ID: 20927527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular ultrasound imaging using contrast agents targeting endoglin, vascular endothelial growth factor receptor 2 and integrin.
    Leguerney I; Scoazec JY; Gadot N; Robin N; Pénault-Llorca F; Victorin S; Lassau N
    Ultrasound Med Biol; 2015 Jan; 41(1):197-207. PubMed ID: 25308938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
    Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
    Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase shift variance imaging - a new technique for destructive microbubble imaging.
    Siepmann M; Fokong S; Mienkina M; Lederle W; Kiessling F; Gätjens J; Schmitz G
    IEEE Trans Ultrason Ferroelectr Freq Control; 2013 May; 60(5):909-23. PubMed ID: 23661125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound contrast agents as markers of vascularity and microcirculation.
    Greis C
    Clin Hemorheol Microcirc; 2009; 43(1-2):1-9. PubMed ID: 19713597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
    Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
    Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
    Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
    Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.